1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. France >
  5. Döhler Acquires Natural Origins

M&A Deal Summary

Döhler Acquires Natural Origins

On April 12, 2017, Döhler acquired consumer products company Natural Origins from ArchiMed

Acquisition Highlights
  • This is Döhler’s 1st transaction in the Consumer Products sector.
  • This is Döhler’s 1st transaction in France.

M&A Deal Summary
Date 2017-04-12
Target Natural Origins
Sector Consumer Products
Buyer(s) Döhler
Sellers(s) ArchiMed
Deal Type Add-on Acquisition

Target

Natural Origins

Lozanne, France
Natural Origins is a provider of medicinal plants from the International Pharmacopeia for the nutraceutical and pharmaceutical industries. Natural Origins is able to source, transform and deliver almost all existing medicinal plants in all possible forms to end-product manufacturers. The company has developed a unique expertise in medicinal botany and built direct relationships with suppliers around the world. Natural Origins was founded in 1999 and is based in Lozanne, France.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Döhler

Darmstadt, Germany
Category Company
Founded 1837
Sector Food
DESCRIPTION

Döhler is a producer, marketer and provider of technology-driven natural ingredients, ingredient systems and integrated solutions for the global food, beverage and nutrition industry. Döhler was founded in 1837 and is based in Darmstadt, Germany.

DEAL STATS #
Overall 2 of 2
Sector: Consumer Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 2 of 2
Country: France M&A 1 of 1
Year: 2017 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-01-15 Molda

Dahlenburg, Germany

Molda specialises in the production and marketing of dried food, non-food and contract drying. Molda was founded in 1892 and is based in Dahlenburg, Germany.

Buy -

Seller(S) 1

SELLER

ArchiMed

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2014
PE ASSETS 8.0B EUR
Size Mega
Type Sector Focused
DESCRIPTION

ArchiMed is a specialist French private equity firm focused on buyouts of and growth capital investments in European healthcare-oriented companies. The Firm looks to invest €10 million to €1 billion per transaction and specifically targets companies in the public health, care and wellness, biotech, and medical technology segments of the healthcare industry. ArchiMed was formed in 2014 and is headquartered in Lyon.

DEAL STATS #
Overall 1 of 9
Sector: Consumer Products M&A 1 of 2
Type: Add-on Acquisition M&A Deals 1 of 8
Country: France M&A 1 of 3
Year: 2017 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-09-20 Polyplus

Illkirch, France

Polyplus is a biotechnology company that supports Gene and Cell therapy, biologics manufacturing, and life science research with innovative nucleic acid transfection solutions. Polyplus was founded in 2001 and is based in Illkirch, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-04-09 Soest Medical Group

Soest, Netherlands

Soest Medical Group is a provider in the production and distribution of medical adhesive tapes, both for reusable and disposable garments used in the operating theatre. SMG started as a manufacturer of adhesive tapes for the reusable drapes industry with the Eurotape brand. Soest diversified into the disposable space with a second brand Somed launched in 2007. Soest Medical Group was founded in 1990 and is based in Soest, The Netherlands.

Buy -
Mergr

Solution for

Product

Company

Legal